Visited, the travel app, has published the 10 least frequented countries by Americans. Visited App allows users to map their travel journey and tick off famous places on the list features, including art museums, ancien...

Eupepsia Wellness Resort BLAND, Va. - August 30, 2022 - (Newswire.com) ...

BankLine & B4U Bring Crypto Payments To Cannabis BankLine and B4U Financial have aligned to provide Cannabis-Related Businesses with an integrated Point of Sale (POS) solution for retail digital...

While traditional eye drop bottles require hand-eye coordination and deliver four to five times more medication than the human eye can hold, the Optejet® dispenser's human-centric design administers an easier, more accurate and appropriate dose directly where it is needed in the eye.

NEW YORK - August 30, 2022 - (Newswire.com)

Eyenovia, Inc. (NASDAQ: EYEN), an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP™) therapeutics, brings human-centric design to ophthalmology with its novel Optejet® dispenser. 

Traditional eye drops normally overdose the patient's eye with medication and preservatives. Eyenovia's easy-to-use, novel Optejet® dispenser administers precisely 8µL of medication to the eye, effectively treating the patient's condition while creating a more gentle dosing experience. 

"The unique delivery mechanism of the Optejet® will fundamentally change how we think about eye medication," said Michael Rowe, CEO of Eyenovia. "Right now, traditional eye drops can result in significant dose-related side effects for the treatment of chronic illnesses like glaucoma. The Optejet® dispenser is designed for patients to experience easier administration and fewer side effects with similar efficacy."

The Optejet® dispenser administers ophthalmic solutions horizontally using Eyenovia's proprietary Microdose Array Print (MAP™) technology. The system functions similar to an inkjet printer, delivering accurate microdoses through a precision spray. Traditional eye drops deliver four to five times larger volume than the human eye can actually hold, which causes eye drops to roll down the face and overdose the eye with preservatives. 

Poor delivery of eye drops is more than an inconvenience; it can prevent patients from using necessary medication because of the side effects. For example, with medication to help dilate the pupils for eye exams, up to 23% of patients experienced stinging and burning with the eye drops, causing patients to forgo eye exams. In Eyenovia studies, less than 1% of patients experienced stinging and burning. 

"Medications only work if patients take them, and with the Optejet, we have designed a way for patients to benefit from an easy-to-use, appropriate, lower dose spray that results in similar efficacy. We're excited for physicians and providers to be able to offer this revolutionary technology in the near future to patients who deserve a more positive experience," said Rowe.

Eyenovia's first marketed invention is expected to be MydCombi™, a first-in-class drug-device combination microdose for in-office pupil dilation. This potentially will help save physician's chair time, eliminating the traditional three eyedrops used for a patient's eye exam. Other exciting innovations in the Eyenovia pipeline include MicroLine (for the treatment of Presbyopia) and MicroPine (for the treatment of Myopia).

For more information, visit eyenovia.com.

About Eyenovia, Inc.

Eyenovia, Inc. (NASDAQ: EYEN) is an ophthalmic pharmaceutical technology company developing a pipeline of microdose array print (MAP) therapeutics. Eyenovia is currently focused on the late-stage development of microdosed medications for mydriasis, presbyopia, and myopia progression. For more information, visit www.eyenovia.com.

Forward-Looking Statements

Except for historical information, all of the statements, expectations and assumptions contained in this press release are forward-looking statements. Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions, including estimated market opportunities for our product candidates and platform technology. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and in some cases are likely to, differ materially from what is expressed or forecasted in the forward-looking statements due to numerous factors discussed from time to time in documents that we file with the U.S. Securities and Exchange Commission. In addition, such statements could be affected by risks and uncertainties related to, among other things: risks of our clinical trials, including, but not limited to, the costs, design, initiation and enrollment (which could still be adversely impacted by COVID-19), timing, progress and results of such trials; the timing of, and our ability to submit applications for, obtaining and maintaining regulatory approvals for our product candidates; the potential impacts of COVID-19 on our supply chain; the potential advantages of our product candidates and platform technology; the rate and degree of market acceptance and clinical utility of our product candidates; our estimates regarding the potential market opportunity for our product candidates; reliance on third parties to develop and commercialize our product candidates; the ability of us and our partners to timely develop, implement and maintain manufacturing, commercialization and marketing capabilities and strategies for our product candidates; intellectual property risks; changes in legal, regulatory and legislative environments in the markets in which we operate and the impact of these changes on our ability to obtain regulatory approval for our products; and our competitive position. Any forward-looking statements speak only as of the date on which they are made, and except as may be required under applicable securities laws. Eyenovia does not undertake any obligation to update any forward-looking statements.

Eyenovia Contact:

Eyenovia, Inc.
John Gandolfo
Chief Financial Officer
[email protected]

Eyenovia Investor Contact:
Eric Ribner
LifeSci Advisors, LLC
[email protected]
(646) 751-4363

Eyenovia Media Contact:
Eyenovia, Inc.
Norbert Lowe
Vice President, Commercial Operations
[email protected]

Press Release Service by Newswire.com

Original Source: Eyenovia's Novel Optejet® Dispenser Puts People's Eyes First

Addition of TaylorMade's San Antonio facility expands PLA's asset-based footprint and strengthens service capabilities.

DALLAS - August 30, 2022 - (Newswire.com)

Pallet Logistics of America ("PLA" or the "Company"), a portfolio company of Silver Oak Services Partners, LLC ("Silver Oak") and an asset-based pallet management services provider, has acquired TaylorMade Pallets & Logistics ("TaylorMade"), the largest independently-owned pallet company in Central/South Texas. Founded in 2000 by Jeff and Jenny Gill, TaylorMade is a family-owned and operated provider of new, recycled, remanufactured, and custom-sized pallets. With a 17-acre facility in San Antonio, Texas, TaylorMade serves a highly-diversified customer base, including various Fortune 500 companies.

The acquisition of TaylorMade brings PLA's asset network to 77 facilities and expands the Company's capacity and service capabilities within the South Texas market. "We are honored to join the PLA Family of Companies," said Byron Evans, CEO of TaylorMade. "Our entire team is looking forward to offering South Texas an even broader array of pallet and logistics services through PLA's expansive network and capacity."

"I'm proud to welcome TaylorMade to the PLA Family of Companies," said Kyle Otting, CEO of PLA. "TaylorMade's highly-efficient operations, dedication to quality, and commitment to their customers have earned them their position as one of the leading pallet operators in South Texas." 

Wade Glisson, Partner at Silver Oak, added, "We are excited to partner with the Gill family, Byron Evans, and the entire team at TaylorMade, and look forward to supporting their continued growth. TaylorMade represents the sixth strategic partnership within the PLA platform, further expanding our footprint and enhancing our service capabilities." 

About PLA

Founded in 1989 and headquartered in Dallas, Texas, PLA is a national supply chain solutions provider offering Pallet Management Services, 3PL Services, Reverse Logistics Services, and Freight Brokerage & Transportation Management Services, handling more than 115 million pallets per year for over 500 customers. Operating under the Pallet Logistics of America, Pallet Repair Services ("PRS"), Pal-Serv, Propak, TaylorMade, Valley Pallet, and Yancey Pallet brands, PLA operates over 75 facilities across the U.S., providing a comprehensive suite of supply chain management solutions. Learn more at www.plasolutions.com.

About TaylorMade Pallets & Logistics 

Founded in 2000 by Jeff and Jenny Gill, TaylorMade is a family-owned and operated provider of recycled, new, and custom-sized pallets. Based in San Antonio, Texas, the company is the largest independently owned pallet company in Central/South Texas, with a 17-acre facility and over 100 trailers. Learn more at www.taylormadepallets.com.

About Silver Oak Services Partners

Founded in 2005 and based in Evanston, IL, Silver Oak Services Partners, LLC ("Silver Oak") is a lower-middle market private equity firm focused on partnering with exceptional management teams to build industry-leading business, consumer, and healthcare service companies. Silver Oak utilizes a proactive, research-led investment process to identify attractive services sectors and seek out the best potential management teams and investment opportunities. Silver Oak seeks to make control investments in leading service businesses with $15 to $150 million in revenue. The firm is currently investing out of its fourth fund, a $500 million investment vehicle. Learn more at www.silveroaksp.com. 

Media Contact

Hillary McCutcheon, Freshwater Marketing
[email protected]

Press Release Service by Newswire.com

Original Source: PLA Acquires TaylorMade Pallets & Logistics

WARNER, N.H - August 30, 2022 - (Newswire.com)

MadgeTech, a leading data logger manufacturer, announces the expanded temperature range of the HiTemp140-FP data logger with the ability to monitor and record temperatures from -200 °C to +260 °C (-328 °F to +500 °F).

Designed for high-temperature applications, including autoclave validation, food processing, and mapping studies, the HiTemp140-FP is made of stainless steel and features an RTD sensor with PFA insulated cable, available in lengths from six to 72 inches. All probe lengths are available with either a stainless-steel tip for easy placement into vials or test tubes, or a bare version for use with accessories such as the CF200 for canning application or the MicroDisc for surface temperature monitoring. 

The expanded temperature range now enables the HiTemp140-FP to monitor temperatures as low as -200 °C (-328 °F), making it a multi-use solution for both high and low temperatures. The body of the HiTemp140 can withstand temperatures from -40 °C to +140 °C (-40 °F to +284 °F)

For more information on the HiTemp140-FP, please contact MadgeTech at [email protected]. 

About MadgeTech
Headquartered in Warner, New Hampshire, MadgeTech has over 25 years of experience in the engineering and manufacturing of data loggers. As an ISO 9001 company, MadgeTech is built on the founding principles of quality, customer satisfaction, and consistent improvement. MadgeTech offers a range of data loggers capable of measuring over 10 different parameters and features an in-house ISO 17025 certified calibration laboratory. 

Press Release Service by Newswire.com

Original Source: MadgeTech's HiTemp140-FP Expands Temperature Range

One of the nation's largest health systems sees a 9x ROI with Cedar Pay; demonstrates impact of investing in the consumer experience

NEW YORK, NY and WINSTON-SALEM, N.C. - August 30, 2022 - (Newswire.com)

Novant Health, one of the largest healthcare systems in the Southeast, has significantly improved its patient financial experience by partnering with Cedar, an enterprise healthcare engagement platform that improves the end-to-end consumer financial journey. By investing in Cedar Pay, Cedar's post-visit billing and payment platform, Novant Health continues to lead the way when it comes to bringing digital innovation to the revenue cycle.

For years, Novant Health had worked to modernize their revenue cycle organization, leaning on mail, email and EHR communications to reach patients. While these initiatives drove incremental improvements, the health system identified two key opportunities in 2019 to truly enable a more consumer-centric experience for their patients:

1. Combining Novant Health's acute and ambulatory services into a single billing experience. While the organization had tried to combine physician and facility billing for years, they had always been met with pushback from vendors or complex EHR upgrades that could fundamentally break their existing processes. 
    
2. Making bill payment a low friction, easy to navigate experience for both patients and team members. Novant Health wanted to help patients understand how their payments work and how their insurance benefits applied. In order to do so, they needed to personalize the experience, using mobile technology that consumers were already familiar with. 

To address these challenges, Novant Health invested in Cedar Pay. Cedar Pay delivers personalized billing through outreach, messaging and bill resolution based on a variety of unique factors and preferences. The platform is fully integrated with Novant Health's existing Epic EHR system across both hospital billing and physician billing. 

As a result of their implementation of Cedar Pay, Novant Health has seen a material rise in collections over a 12-month period, amounting to tens of millions of dollars, as well as: 

• 90% patient satisfaction score
• 87% of collections now completely self-serviced
• 43% drop in days to collect

"Investing in a consumer engagement platform like Cedar is something we had wanted to do for a long time as part of our digital transformation strategy—we wanted to create a singular financial experience that allows our patients to pay with the technology we keep in our pockets," said Geoff Gardner, senior vice president of Finance at Novant Health. "Cedar has been a great partner to us in our commitment to delivering a remarkable healthcare experience to our community; the results truly speak for themselves, as we have been able to increase collections while also improving patient satisfaction." 

"At Cedar, we know that engaged, happy patients lead to better outcomes, and the best way to improve patient satisfaction is by implementing consumer-friendly technology," said Florian Otto, CEO and co-founder of Cedar. "It's been a privilege working with such an innovative health system like Novant Health, and we look forward to continuing our partnership and continuing to impact the lives of their patients." 

To learn more about how Novant Health has seen a 9x ROI through its strategic partnership with Cedar, read the full case study here.

About Cedar

Cedar is committed to improving the healthcare billing experience for all. With an innovative platform that connects providers and payers, Cedar empowers healthcare consumers with a personalized journey—all powered by data science and interactive design. For Cedar clients, this leads to increased collections, more efficient operations and greater consumer loyalty. To learn more about why leading U.S. healthcare organizations trust Cedar to manage the end-to-end consumer experience from pre-registration to post-visit billing, visit www.cedar.com and join us on LinkedIn, Twitter, Facebook and YouTube.

About Novant Health

Novant Health is an integrated network of physician clinics, outpatient facilities and hospitals that delivers a seamless and convenient healthcare experience to communities in North Carolina, South Carolina, Virginia and Georgia. The Novant Health network consists of more than 1,800 physicians and over 35,000 employees who provide care at nearly 800 locations, including 15 hospitals and hundreds of outpatient facilities and physician clinics. In 2021, Novant Health was the highest-ranking healthcare system in North Carolina to be included on Forbes' Best Employers for Diversity list. Diversity MBA Magazine ranked Novant Health first in the nation on its 2021 list of "Best Places for Women & Diverse Managers to Work." In 2020, Novant Health provided more than $1.02 billion in community benefit, including financial assistance and services.

For more information, please visit our website at NovantHealth.org. You can also follow us on Twitter and Facebook.

Contact

For Cedar
Jenny Fiegoli
PR & Communications Manager
[email protected] 

For Novant Health
Novant Health media relations
844-536-3288 (this number does not accept text messages)
[email protected]

Press Release Service by Newswire.com

Original Source: Novant Health Improves Patient Collection Rates and Satisfaction Through Partnership With Cedar

The expanded solution solves significant challenges facing healthcare providers today by providing key outsourced services. MEDHOST logo ...

The research will be presented at the European Congress of Pathology (ECP) 2022 TEL AVIV, Israel - ...

Chiropractic, massage and acupuncture company making a mark in the community.

RALEIGH, N.C. - August 30, 2022 - (Newswire.com)

Today, Merkados™, RDU-based digital media marketing agency, has announced the launch of the Chiropractic Partners of Clayton new bilingual, English and Spanish, website. The mobile-friendly, accessible, fast, secure and beautifully designed site can be accessed now at: https://chiropartnersclayton.com/. This is great news for those in the community, including the Hispanic population, who are looking for quality chiropractic care and a contemporary way to request chiropractic appointments from the convenience of their mobile device.

The website is designed to provide a great user experience with easy navigation, access to important information about the practice, the ability to request appointments online, and created with a powerful content management system that helps administrators update the information in real time. The site is also built to be WCAG 2.1. AA-compliant, meaning that it can be used by patients with ease. Also, the new website has been optimized for low loading times from any device, even smaller smartphones.

"We are very happy with what Merkados has done for us. They did a fantastic job with the new website, and doing so quickly, efficiently and taking all of our concerns seriously. Our branding and new site have been refreshed, and they speak clearly about our business' core values: safe, gentle, thoughtful and transformative. The website looks contemporary, professional and welcoming and is very user-friendly. We are extremely satisfied with the result and recommend Merkados to any business looking for professional and strategic digital media," said Dr. Ferez, owner at Chiropractic Partners of Clayton.

This is a great resource for the community, both English and Spanish-speaking, and a valuable addition to the local business landscape. To learn more, please visit the website at: https://merkados.com.

Press Release Service by Newswire.com

Original Source: Merkados™ Announces Design of Bilingual English-Spanish 'Chiropractic Partners of Clayton' Website